BioMind
BioMind view 1
BioMind view 2
BioMind view 3
Peptide Capsules
Verified Quality

BioMind

4.88 (34 Reviews)
Ships worldwide
$349.97

Sales Tax included at checkout

Laboratory Research Chemical • Scroll down for full specifications

1

Priority Shipping

Fast & Discreet

99% Purity

HPLC Verified

Full Refund

60-Day Promise

Lab Synthesis

GMP Certified

Product Information

Detailed laboratory specifications, compound structure, and research applications.

Research Grade

HPLC 99%+ Purity

Verified Origin

GMP Manufactured

What Is BioMind?

BioMind is a three-in-one neurocognitive research compound designed to explore neuroplasticity, cognitive function, and neuroprotection in a research environment. It combines J-147, Dihexa, and Noopept, which individually and synergistically support brain health and resilience against neurodegeneration.

  • J-147 (10mg per serving *): A neuroprotective compound that modulates mitochondrial function and increases BDNF, which leads to the reduction of neuroinflammation and oxidative stress while possibly improving cognitive function.
  • Dihexa (10mg per serving *): A synaptic growth promoter that enhances neural connectivity and repair, mimicking natural neurotrophic factors like HGF.
  • Noopept (10mg per serving *): A dipeptide nootropic that modulates neurotransmission and protects neurons from excitotoxicity.

* serving size = 2 capsules

Together, these compounds offer a unique research opportunity to study cognitive resilience, neurodegenerative disease mechanisms, and neural regeneration in preclinical models.

BioMind Research Compounds and Mechanisms

  1. J-147 – Mitochondrial Modulation and Neuroprotection

J-147 is a novel neuroprotective agent that enhances mitochondrial function, promotes cellular longevity pathways, and protects against oxidative stress.

  • Increases levels of brain-derived neurotrophic factor (BDNF), promoting neuroplasticity.
  • Modulates AMPK/mTOR pathways, which are linked to cellular energy regulation and anti-aging effects.
  • Protects neurons from oxidative stress and excitotoxicity, reducing markers of neuroinflammation and neuronal death.
  • Improves memory and learning ability in preclinical models of Alzheimer’s disease and cognitive decline.
  • Crosses the blood-brain barrier efficiently, enabling direct action on brain mitochondria and synapses.

Research has demonstrated J-147’s ability to reverse cognitive deficits, reduce amyloid plaque burden, and enhance synaptic density, making it a valuable tool for studying neurodegeneration, cognitive enhancement, and longevity pathways.

  1. Dihexa – Synaptogenesis and Neural Repair

Dihexa is a synthetic neurotrophic compound derived from angiotensin IV, designed to stimulate synapse formation and neural repair.

  • Binds and activates hepatocyte growth factor (HGF) receptors, promoting synaptogenesis and neural connectivity.
  • Enhances long-term potentiation (LTP), a fundamental mechanism for memory consolidation and learning.
  • Protects neurons from glial activation, neuroinflammation, and oxidative stress.
  • Crosses the blood-brain barrier and remains active in neural tissue for extended periods.
  • Has demonstrated restorative effects in Alzheimer’s disease models, showing memory recovery and increased synaptic density.

Dihexa’s unique mechanisms of action makes it a valuable research compound for exploring cognitive resilience, neuroregeneration, and neurodegenerative disease pathways.

  1. Noopept – Neuroprotection

Noopept is a dipeptide-derived nootropic with rapid absorption and neuroprotective effects.

  • Modulates AMPA and NMDA glutamate receptors, supporting synaptic signaling and plasticity.
  • Enhances acetylcholine transmission, contributing to improved focus, memory, and recall.
  • Increases NGF (nerve growth factor) and BDNF, reinforcing neuronal survival and growth.
  • Provides anti-inflammatory and antioxidant effects, reducing neuronal damage from stressors.
  • Has been shown to reverse memory deficits in models of neurodegeneration and aging.

Noopept’s short half-life and rapid neuroactive conversion make it a prime candidate for investigating acute cognitive enhancement, synaptic signaling, and neuroprotection in preclinical settings.

Synergistic Effects of J-147, Dihexa, and Noopept

BioMind contains three complementary neuroactive compounds that interact to support cognitive enhancement and neuroprotection:

  • J-147 increases BDNF and promotes mitochondrial function, creating a favorable environment for synaptic plasticity.
  • Dihexa enhances neural connectivity and synaptic repair, making new neural pathways more resilient.
  • Noopept amplifies neurotransmission efficiency, improving short-term memory and cognitive processing.

Together, these compounds provide a unique opportunity to study neurodegeneration, cognitive enhancement, and neuronal repair mechanisms in a multi-target research framework.

Molecular Structure and Data

J-147

  • Chemical Name: N-(2,4-dimethylphenyl)-2,2,2-trifluoro-N’-(3-methoxybenzyl)hydrazine
  • CAS Number: 1146963-51-0
  • Molecular Formula: C₁₈H₁₇F₃N₂O₂
  • Molecular Weight: 350.34 g/mol

Dihexa

  • Chemical Name: N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide
  • CAS Number: 1401708-83-5
  • Molecular Formula: C₂₇H₄₄N₄O₅
  • Molecular Weight: 504.7 g/mol

Noopept

  • Chemical Name: N-phenylacetyl-L-prolylglycine ethyl ester
  • CAS Number: 157115-85-0
  • Molecular Formula: C₁₇H₂₂N₂O₄

Molecular Weight: 318.4 g/mol

Research Chemical Disclaimer

This product is intended for laboratory research use only. It is not for human consumption, diagnostic, or therapeutic purposes. Handling should only be performed by qualified professionals.

Complete Your Research

Synergistic compounds from the Peptide Capsules lineup

View Full Collection
MicroFLGR (2MG)

MicroFLGR (2MG)

Product Description

Follistatin (FLGR242), is a novel fragmented, modified version of Follistatin-344 (FST-344) that does not bind to the protein activin. Activin is responsible for the negative effects of myostatin inhibition such as unwanted cellular growth in laboratory models. It also contains a patented albumin binder.

Follistatin protein (FST) fused with an albumin-binding construct that uses a hydrophilic glycine-serine linker to achieve high-affinity binding to serum albumin (<20 nM Kd). This recombinant technology allows researchers to study follistatin-albumin interactions and protein trafficking in experimental systems.

Research applications include muscle mass development studies, activin neutralization assays, and TGF-β superfamily pathway modulation with albumin binding dynamics. The construct maintains biological activity while enabling investigation of albumin as a carrier protein.

US GMP-manufactured with third-party verification and comprehensive COAs for reproducible research outcomes.

Peptide Information

Property Value
Peptide Type Follistatin-Albumin Binding Construct
Technology Albumin-binding peptide fusion (GGSGGSGGSGGRLIEDICLPRWGCLWEDD linker)
Molecular Weight ~40 kDa
Binding Affinity <20 nM
Synonyms FST-Albumin Construct, Extended Half-Life Follistatin

Lyophilized Peptides:

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.

Product Usage:

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only.  This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.

$15000.00

Follistatin (FLGR242) (10mg)
Options

Follistatin (FLGR242) (10mg)

Product Description

Follistatin (FLGR242), is a novel fragmented, modified version of Follistatin-344 (FST-344) that does not bind to the protein activin. Activin is responsible for the negative effects of myostatin inhibition such as unwanted cellular growth in laboratory models. It also contains a patented albumin binder.

Follistatin protein (FST) fused with an albumin-binding construct that uses a hydrophilic glycine-serine linker to achieve high-affinity binding to serum albumin (<20 nM Kd). This recombinant technology allows researchers to study follistatin-albumin interactions and protein trafficking in experimental systems.

Research applications include muscle mass development studies, activin neutralization assays, and TGF-β superfamily pathway modulation with albumin binding dynamics. The construct maintains biological activity while enabling investigation of albumin as a carrier protein.

US GMP-manufactured with third-party verification and comprehensive COAs for reproducible research outcomes.

Peptide Information

Property Value
Peptide Type Follistatin-Albumin Binding Construct
Technology Albumin-binding peptide fusion (GGSGGSGGSGGRLIEDICLPRWGCLWEDD linker)
Molecular Weight ~40 kDa
Binding Affinity <20 nM
Synonyms FST-Albumin Construct, Extended Half-Life Follistatin

Lyophilized Peptides:

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.

Product Usage:

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only.  This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.

$2397 – $28764

Klotho (alphaKlothoLR) (20mcg)
Options

Klotho (alphaKlothoLR) (20mcg)

Product Description

alphaKlothoLR is a patented, long-release version of the recombinant Klotho protein, which contains specific amino acid sequences, linkers, and an albumin binding group that allows for a sustained delivery of Klotho with cellular activity up to 19 days.

This research-grade construct combines α-Klotho protein with a proprietary 29-amino acid albumin binding peptide (GGSGGSGGSGGRLIEDICLPRWGCLWEDD). The modification enables strong albumin binding affinity (<20 nM) while maintaining native FGF23 binding activity (15-30 nM).

Produced through recombinant expression with rigorous third-party testing. Each batch includes HPLC and LC-MS verification to confirm molecular identity and purity standards. Complete analytical documentation supports laboratory applications investigating protein-albumin interactions, FGF23 signaling pathways, and albumin binding mechanisms.

For in vitro research use only.

Klotho Protein Information

Property Value
Peptide Sequence α-Klotho protein (1012 amino acids) + albumin binding construct: GGSGGSGGSGGRLIEDICLPRWGCLWEDD
Molecular Weight ~133-135 kDa (full construct with albumin binder)
Albumin Binding Affinity (Kd) <20 nM
FGF23 Binding Affinity (Kd) 15-30 nM (optimized: 16.2 nM)
Synonyms α-Klotho-albumin binding construct, Modified Klotho with glycine-serine linker

Lyophilized Peptides:

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.

Product Usage:

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only.  This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.

$2397 – $15341

Research Specification

Comprehensive documentation for laboratory application and compound verification.

HPLC Verification

Purity levels exceeding 99.2% guaranteed via third-party high-performance liquid chromatography testing.

Storage Compliance

Stored at -20°C in oxygen-free environment. Shipped with cold-chain monitoring protocols.

CAS Registry

Uniquely identified compound with full structural validation and mass spectrometry reports.

Usage Policy

Strictly for lab research. Not for human or therapeutic use. Waiver required for bulk orders.